Smart ring maker Oura is set to test the public markets with a Nasdaq listing under the ticker OURA. The company is seeking a valuation of $15.62 billion and aims to raise up to $2.2 billion, according to Reuters. The move comes as the IPO market shows signs of thawing after a period of caution among investors.
Oura, best known for its sleek rings that track sleep, heart rate, and activity, is pitching itself as a fast-growing player in the wearables space. The company reported revenue of $1.21 billion for the nine months ended June 30th, up about 74% year-over-year. That growth reflects a broader trend of consumers increasingly paying for health and fitness tracking, both for personal wellness and as part of corporate wellness programs.
What Oura does and why it matters
Oura's flagship product is a ring packed with sensors that monitor physiological signals like heart rate variability, body temperature, and sleep stages. Unlike smartwatches, which often serve as extensions of a phone, Oura's ring is designed to be worn continuously and focuses on recovery and readiness. The company has built a subscription service around the hardware, with users paying a monthly fee for deeper insights and personalized recommendations.
This business model—selling hardware plus a recurring subscription—has become increasingly popular in the consumer health tech space. It provides a more predictable revenue stream than one-off device sales. Oura's growth suggests that consumers are willing to pay for data-driven health insights, a trend that has also benefited other wearables makers and health apps.
The smart ring category is still relatively niche compared to smartwatches, but it has been gaining traction. Oura faces competition from larger tech companies and startups, but its focus on the ring form factor and its strong brand among athletes and wellness enthusiasts have helped it stand out.
The IPO market context
Oura's listing comes at a time when the IPO market has been cautious. After a volatile period for stocks, investors have become more selective, favoring companies with clear paths to profitability and strong growth. Oura's revenue growth is a key selling point, but the company is still not profitable, which could be a point of scrutiny.
The broader market has also been dealing with rising interest rates, which can pressure valuations for growth stocks. As noted in a recent article on Treasury yields, higher yields make future earnings less valuable, which can weigh on high-multiple stocks. However, Oura's strong revenue growth may help it justify a rich valuation.
Other recent IPOs have shown mixed results. Some, like ADARx's Nasdaq IPO, have attracted attention, but the market remains selective. Oura's success could encourage other consumer tech companies to move forward with their own listings.
What it means for investors
For everyday investors, Oura's IPO offers a chance to own a piece of a fast-growing consumer health tech company. But it's important to understand the risks. The company is not yet profitable, and the wearables market is competitive. Oura will need to continue innovating and expanding its subscription base to justify its valuation.
Investors should also consider the broader trend of health and wellness technology. The pandemic accelerated interest in personal health monitoring, and that trend appears to be sticking. Oura is well-positioned to benefit, but it's not the only player. Larger companies like Apple and Samsung are also investing heavily in health features for their devices.
The IPO price and valuation will be key. A $15.62 billion valuation is substantial for a company with $1.21 billion in trailing nine-month revenue, implying a price-to-sales ratio of roughly 13 times. That's a high multiple, but not unusual for a high-growth tech company. Investors will be watching to see if Oura can maintain its growth pace and move toward profitability.
As with any IPO, there's also the risk of volatility in the early days of trading. Shares can swing sharply as the market adjusts to the new supply. Long-term investors may want to wait for the stock to settle before making any decisions.
What to watch next
Oura's roadshow will be closely watched for signs of investor demand. The company will need to convince institutional investors that its growth is sustainable and that it can fend off competition. The final IPO price will be set based on that feedback, and it could come in above or below the range initially expected.
Beyond the IPO, investors will be looking at Oura's subscription numbers and its ability to expand into new markets. The company has already made inroads with corporate wellness programs, which could be a significant growth driver. If Oura can demonstrate that its subscription base is growing and retention is high, that would be a positive sign.
For now, Oura's IPO is a signal that the market for new listings is opening up, at least for companies with strong growth stories. Whether that trend continues will depend on broader market conditions and how these newly public companies perform.
